Inadequate Encryption Strength Vulnerability in Roche Algo Edge
Key facts
- Attack vector
- Adjacent network
- Privileges required
- None
- User interaction
- None
- Attack complexity
- High
- Attack requirements
- Present
- Impact type
- Information disclosure
- Confidentiality · integrity · availability
- Low · High · High
- Fix status
- Fixed
Attack profile from CVSS 4.0 · CNA. Fix status from CNA. Impact type from CWE-326.
Summary
A vulnerability exists in Algo Edge up to 2.1.1 - a previously used (legacy) component of navify® Algorithm Suite. The vulnerability impacts the authentication mechanism of this component and could allow an attacker with adjacent access to the laboratory network and the Algo Edge system to craft valid authentication tokens and access the component. Other components of navify® Algorithm Suite are not affected.
Why it matters now
SSVC decision points
CISA ADP · SSVC 2.0.3
- Exploitation
- None
- Automatable
- No
- Technical impact
- Total
The decision (Track, Attend, Act) also depends on your mission and well-being impact; see CISA's SSVC guide.
Affected products
| Vendor | Product | Affected versions | Fixed in | Status | Source |
|---|---|---|---|---|---|
| Roche Diagnostics | Algorithm Suite | before 2.1.2 | 2.1.2 | Patch available | CNA |
- Algorithm Suite VendorRoche Diagnostics Affected before 2.1.2 Fixed in 2.1.2 Patch available CNA
Remediation
- Fix · CNA Algorithm Suite (Roche Diagnostics) Fixed in 2.1.2
Timeline
- 2026-10-02 Threatist record created from CVE-2024-13026
- 2026-10-03 Alias added: GHSA-mvrq-wf2x-8c9p
References
More Roche Diagnostics vulnerabilities
- TI-2026-08618 Vulnerability in navify® Digital Pathology CVSS 4.0HIGH 8.8
- TI-2025-07005 navify Monitoring API input validation CVSS 4.0HIGH 7.1
Sources
- CVE-2024-13026 · CVE Program
- CVE-2024-13026 · NVD
- FIRST EPSS
- GHSA-mvrq-wf2x-8c9p · GitHub Advisory Database · CC BY 4.0
This product uses the NVD API but is not endorsed or certified by the NVD. Sources and licences